Search Results
Results found for "Kevin Pfleger"
Posts (8)
- Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was appointed...
December 2021 Perkins’ Head of Molecular Endocrinology and Pharmacology, Professor Kevin Pfleger, was Coincidentally, on the same day, Prof Pfleger was announced as a Fellow of the British Pharmacological Prof Pfleger has served on the ASCEPT Board since 2016 and was Chair of the Scientific Advisory Committee
- Dr. Kevin Pfleger and Dr. Elizabeth Johnstone were awarded one of the 2022 Diabetes Research...
Kevin Pfleger and Dr. "Congratulations to Perkins Professor Kevin Pfleger and Dr Elizabeth Johnstone who were awarded one of
- A2A Fluorescent Competitive Binding: Advancing NanoBRET® Target Engagement for GPCR Drug Discovery
A new NanoBRET® competitive binding assay 2  was developed in collaboration with Professor Kevin Pfleger Pfleger’s group in developing assays, led to two new A 2A AR tracers (CELT-463 and CELT-464) , bearing J.; Pfleger, K. D. G. Application of BRET to Monitor Ligand Binding to GPCRs.
Other Pages (1)
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
Pfleger on NanoBRET live-cell assays, receptor complex pharmacology, and what it took to move GPCR biology from HEK cells to phase 2 clinical trials. << Back to podcast list Strategic Partner(s) Pfleger: NanoBRET Kevin Pfleger's research at the University of Western Australia sits at the intersection of assay technology About the Guest Kevin Pfleger is Professor, Director of Biomedical Innovation, and Head of Molecular Kevin Pfleger on the web LinkedIn ResearchGate Pubmed Google Scholar University of Western Australia
